NEW YORK, Jan 9, 2026, 10:31 EST — Regular session
- TIC Solutions shares climbed about 4.8% after JPMorgan initiated coverage with an Overweight rating and a $16 price target.
- JPMorgan pointed to cross-selling and cost synergies tied to the company’s Acuren-NV5 integration.
- Traders are looking ahead to the next earnings report date on market calendars.
Shares of TIC Solutions rose 4.8% to $11.40 in morning trading on Friday, after JPMorgan initiated coverage with an Overweight rating and a $16 price target. The stock touched $11.66 and traded as low as $11.04.
The call matters because TIC is still being priced like an integration story, not a finished one. The company sells testing, inspection, certification and compliance — TICC, in industry shorthand — along with engineering services that clients often buy to meet safety rules and keep assets running.
TIC Solutions completed a merger with NV5 Global in August 2025 that it said created a $2 billion-plus inspection and engineering services business. In its last quarterly update, Chief Executive Tal Pizzey said the combined platform could “unlock savings and growth,” and the company lifted its identified cost synergy target to $25 million. TIC Solutions
JPMorgan cited a recent visit to TIC’s Cincinnati facility and said it saw progress on integration initiatives, Investing.com reported. The bank also flagged cross-selling — selling more services to existing customers — as a key driver for the shares.
Analyst Tomohiko Sano set the $16 target, GuruFocus wrote. “Overweight” is Wall Street shorthand for a view the stock should outperform its sector or a benchmark, rather than a comment on the company’s balance sheet. GuruFocus
With the stock moving on the broker call, some traders will watch whether TIC can hold above the $11 level into the close, a spot it has already tested several times early Friday.
But the upside case leans on execution. If integration takes longer, costs stay sticky, or customers defer maintenance and compliance work, the path to higher margins can get bumpy fast.
The next obvious catalyst is earnings: Benzinga’s calendar lists Feb. 3 as the next report date. Investors will be looking for updates on synergy capture, cross-selling traction and any change in outlook.
